Competitive binding and metabolism of several carcinogenic polycyclic aromatic hydrocarbons by AKR mouse embryo cells in culture

T. H. Zytkovicz, H. L. Moses, T. C. Spelsberg

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The binding of labeled carcinogens [3H]benzo(a)pyrene [3H]dibenz(a,h)anthracene, and [3H]dibenz(a,c)anthracene to nuclear chromatin was examined in AKR mouse embryo cells grown in culture. The influence of unlabeled weakly and strongly carcinogenic polycyclic aromatic hydrocarbons (PAH) and the metabolic inhibitor 7,8-benzoflavone on the binding of labeled PAH to nuclear chromatin was examined. Several unlabeled, strongly carcinogenic PAH [benzo(a)pyrene, dibenz(a,h)anthracene, dibenz(a,c)anthracene, and 3-methylcholanthrene] and 7,8-benzoflavone effectively inhibited covalent binding of labeled strongly carcinogenic PAH to the nuclear subfractions. The weakly carcinogenic PAH (pyrene and anthracene) had a variable effect. Since the covalent binding of PAH to chromatin is dependent on the metabolism of the parent compounds, the effects of the various unlabeled PAH on metabolism of the labeled PAH were evaluated. The data indicated: (a) that unlabeled strongly carcinogenic PAH inhibited the metabolism of the labeled carcinogenic PAH, thus causing the decreased nuclear binding of the latter; and (b) that unlabeled weakly carcinogenic PAH stimulated the metabolism and had a variable effect on nuclear binding of the strongly carcinogenic PAH. A reciprocal relationship was seen. With higher levels of inhibition, lower amounts of nuclear binding were seen. The ability of various unlabeled PAH to compete with the metabolism and nuclear binding of labeled carcinogenic PAH appears to relate to the carcinogenic potency of the former compounds. The data suggest the existence of a common metabolic pathway for strongly carcinogenic PAH that differs, at least in part, from that of the weakly carcinogenic PAH.

Original languageEnglish (US)
Pages (from-to)2307-2313
Number of pages7
JournalCancer Research
Volume38
Issue number8
StatePublished - 1978

Fingerprint

Inbred AKR Mouse
Competitive Binding
Polycyclic Aromatic Hydrocarbons
Embryonic Structures
Cell Culture Techniques
Chromatin
Benzo(a)pyrene
Methylcholanthrene

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Competitive binding and metabolism of several carcinogenic polycyclic aromatic hydrocarbons by AKR mouse embryo cells in culture. / Zytkovicz, T. H.; Moses, H. L.; Spelsberg, T. C.

In: Cancer Research, Vol. 38, No. 8, 1978, p. 2307-2313.

Research output: Contribution to journalArticle

Zytkovicz, T. H. ; Moses, H. L. ; Spelsberg, T. C. / Competitive binding and metabolism of several carcinogenic polycyclic aromatic hydrocarbons by AKR mouse embryo cells in culture. In: Cancer Research. 1978 ; Vol. 38, No. 8. pp. 2307-2313.
@article{dba62102a5c449d895c557c996871e5f,
title = "Competitive binding and metabolism of several carcinogenic polycyclic aromatic hydrocarbons by AKR mouse embryo cells in culture",
abstract = "The binding of labeled carcinogens [3H]benzo(a)pyrene [3H]dibenz(a,h)anthracene, and [3H]dibenz(a,c)anthracene to nuclear chromatin was examined in AKR mouse embryo cells grown in culture. The influence of unlabeled weakly and strongly carcinogenic polycyclic aromatic hydrocarbons (PAH) and the metabolic inhibitor 7,8-benzoflavone on the binding of labeled PAH to nuclear chromatin was examined. Several unlabeled, strongly carcinogenic PAH [benzo(a)pyrene, dibenz(a,h)anthracene, dibenz(a,c)anthracene, and 3-methylcholanthrene] and 7,8-benzoflavone effectively inhibited covalent binding of labeled strongly carcinogenic PAH to the nuclear subfractions. The weakly carcinogenic PAH (pyrene and anthracene) had a variable effect. Since the covalent binding of PAH to chromatin is dependent on the metabolism of the parent compounds, the effects of the various unlabeled PAH on metabolism of the labeled PAH were evaluated. The data indicated: (a) that unlabeled strongly carcinogenic PAH inhibited the metabolism of the labeled carcinogenic PAH, thus causing the decreased nuclear binding of the latter; and (b) that unlabeled weakly carcinogenic PAH stimulated the metabolism and had a variable effect on nuclear binding of the strongly carcinogenic PAH. A reciprocal relationship was seen. With higher levels of inhibition, lower amounts of nuclear binding were seen. The ability of various unlabeled PAH to compete with the metabolism and nuclear binding of labeled carcinogenic PAH appears to relate to the carcinogenic potency of the former compounds. The data suggest the existence of a common metabolic pathway for strongly carcinogenic PAH that differs, at least in part, from that of the weakly carcinogenic PAH.",
author = "Zytkovicz, {T. H.} and Moses, {H. L.} and Spelsberg, {T. C.}",
year = "1978",
language = "English (US)",
volume = "38",
pages = "2307--2313",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Competitive binding and metabolism of several carcinogenic polycyclic aromatic hydrocarbons by AKR mouse embryo cells in culture

AU - Zytkovicz, T. H.

AU - Moses, H. L.

AU - Spelsberg, T. C.

PY - 1978

Y1 - 1978

N2 - The binding of labeled carcinogens [3H]benzo(a)pyrene [3H]dibenz(a,h)anthracene, and [3H]dibenz(a,c)anthracene to nuclear chromatin was examined in AKR mouse embryo cells grown in culture. The influence of unlabeled weakly and strongly carcinogenic polycyclic aromatic hydrocarbons (PAH) and the metabolic inhibitor 7,8-benzoflavone on the binding of labeled PAH to nuclear chromatin was examined. Several unlabeled, strongly carcinogenic PAH [benzo(a)pyrene, dibenz(a,h)anthracene, dibenz(a,c)anthracene, and 3-methylcholanthrene] and 7,8-benzoflavone effectively inhibited covalent binding of labeled strongly carcinogenic PAH to the nuclear subfractions. The weakly carcinogenic PAH (pyrene and anthracene) had a variable effect. Since the covalent binding of PAH to chromatin is dependent on the metabolism of the parent compounds, the effects of the various unlabeled PAH on metabolism of the labeled PAH were evaluated. The data indicated: (a) that unlabeled strongly carcinogenic PAH inhibited the metabolism of the labeled carcinogenic PAH, thus causing the decreased nuclear binding of the latter; and (b) that unlabeled weakly carcinogenic PAH stimulated the metabolism and had a variable effect on nuclear binding of the strongly carcinogenic PAH. A reciprocal relationship was seen. With higher levels of inhibition, lower amounts of nuclear binding were seen. The ability of various unlabeled PAH to compete with the metabolism and nuclear binding of labeled carcinogenic PAH appears to relate to the carcinogenic potency of the former compounds. The data suggest the existence of a common metabolic pathway for strongly carcinogenic PAH that differs, at least in part, from that of the weakly carcinogenic PAH.

AB - The binding of labeled carcinogens [3H]benzo(a)pyrene [3H]dibenz(a,h)anthracene, and [3H]dibenz(a,c)anthracene to nuclear chromatin was examined in AKR mouse embryo cells grown in culture. The influence of unlabeled weakly and strongly carcinogenic polycyclic aromatic hydrocarbons (PAH) and the metabolic inhibitor 7,8-benzoflavone on the binding of labeled PAH to nuclear chromatin was examined. Several unlabeled, strongly carcinogenic PAH [benzo(a)pyrene, dibenz(a,h)anthracene, dibenz(a,c)anthracene, and 3-methylcholanthrene] and 7,8-benzoflavone effectively inhibited covalent binding of labeled strongly carcinogenic PAH to the nuclear subfractions. The weakly carcinogenic PAH (pyrene and anthracene) had a variable effect. Since the covalent binding of PAH to chromatin is dependent on the metabolism of the parent compounds, the effects of the various unlabeled PAH on metabolism of the labeled PAH were evaluated. The data indicated: (a) that unlabeled strongly carcinogenic PAH inhibited the metabolism of the labeled carcinogenic PAH, thus causing the decreased nuclear binding of the latter; and (b) that unlabeled weakly carcinogenic PAH stimulated the metabolism and had a variable effect on nuclear binding of the strongly carcinogenic PAH. A reciprocal relationship was seen. With higher levels of inhibition, lower amounts of nuclear binding were seen. The ability of various unlabeled PAH to compete with the metabolism and nuclear binding of labeled carcinogenic PAH appears to relate to the carcinogenic potency of the former compounds. The data suggest the existence of a common metabolic pathway for strongly carcinogenic PAH that differs, at least in part, from that of the weakly carcinogenic PAH.

UR - http://www.scopus.com/inward/record.url?scp=0018151117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018151117&partnerID=8YFLogxK

M3 - Article

C2 - 667826

AN - SCOPUS:0018151117

VL - 38

SP - 2307

EP - 2313

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 8

ER -